Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3,12 USD | +2,30 % | -25,36 % | -32,17 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Willard
CEO | Chief Executive Officer | 63 | 12/07/22 |
Jonathan Javitt
FOU | Founder | 67 | 18/09/17 |
Richard Narido
DFI | Director of Finance/CFO | 46 | 13/09/23 |
Chief Tech/Sci/R&D Officer | - | 05/12/22 | |
Rick Panicucci
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Corporate Officer/Principal | - | 01/10/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jonathan Javitt
FOU | Founder | 67 | 18/09/17 |
Stephen Willard
CEO | Chief Executive Officer | 63 | 12/07/22 |
Janet Rehnquist
BRD | Director/Board Member | - | 27/12 |
Patrick J. Flynn
BRD | Director/Board Member | 75 | 24/05/21 |
Chaim Hurvitz
BRD | Director/Board Member | 63 | 24/05/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 10 488 067 | 7 612 875 ( 72,59 %) | 0 | 72,59 % |
Acción B | 0 | 3 000 000 | 0 | 0 |
Información de la empresa
Sector
Ganancias trimestrales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-32,17 % | 32,51 M | |
+4,09 % | 43,84 mil M | |
+47,81 % | 41,25 mil M | |
+9,45 % | 41,68 mil M | |
-10,92 % | 27,04 mil M | |
+9,32 % | 25,53 mil M | |
-24,87 % | 18,18 mil M | |
+29,70 % | 12,29 mil M | |
+1,28 % | 12,29 mil M | |
+7,78 % | 11,15 mil M |
- Bolsa de valores
- Acciones
- Acción BRPA
- Empresa NRx Pharmaceuticals, Inc.